Merck Japanese Supplier Adds Production Line To Meet Demand For Tafluprost
This article was originally published in PharmAsia News
Executive Summary
Asahi Glass Co. April 16 announced a plan to invest ¥800 million for a new production line to manufacture active ingredient tafluprost.